Feasibility and safety of excimer laser coronary angioplasty combined with drug-coated balloon for recurrent in-stent restenosis patients
10.3969/j.issn.1004-8812.2023.11.007
- VernacularTitle:准分子激光冠状动脉成形术联合药物涂层球囊在复发性支架内再狭窄病变中的运用探讨
- Author:
Pan HE
1
,
2
;
Hai-Wei CHEN
;
Jun-Jie YANG
;
Lei GAO
;
Jun GUO
;
Yun-Dai CHEN
;
Qi WANG
Author Information
1. 100853 北京,中国人民解放军总医院第一医学中心心血管内科
2. 中国人民解放军医学院
- Keywords:
Recurrent in-stent restenosis;
Excimer laser coronary angioplasty;
Drug-coated balloon
- From:
Chinese Journal of Interventional Cardiology
2023;31(11):849-854
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the safety and efficacy of combining excimer laser coronary angioplasty with drug-coated balloon in the treatment of recurrent in-stent restenosis(R-ISR).Methods Clinical data from a cohort of 27 patients with a total of 30 R-ISR lesions,who underwent treatment with combined excimer laser coronary angioplasty and drug-coated balloons at our hospital from October 2019 to April 2023,were retrospectively analyzed.Patient baseline information,coronary angiography results,procedural details,and in-hospital complications were collected.Follow-up assessments were conducted at 1,3,and 6 months post-intervention to document major clinical events.Results A total of 27 patients[mean age(66.4±9.8)years]with 30 lesions(100%)achieved procedural and treatment success.There were no cases of acute myocardial infarction,coronary perforation,cardiac tamponade,urgent target lesion revascularization,or death during hospitalization.After 6 months of follow-up,there were no occurrences of acute myocardial infarction or death.Two patients(with a total of two lesions)underwent target lesion revascularization,one patient received repeated drug-balloon dilatation,and one patient underwent coronary artery bypass grafting.Conclusions Excimer laser coronary angioplasty combined with drug-coated balloons is a safe and effective treatment strategy for recurrent in-stent stenosis,but further studies are needed for confirmation.